2 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow ZYUS Life Sciences Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Unique Treatment of Oncology Pain in Advanced Cancer Trichomylin® capsule (5 mg delta-9-tetrahydrocannabinol: 5 mg cannabidiol: 5 mg cannabichromene) - Cancer Pain | Phase 2 | Completed | ZYUS Life Sciences Inc. | 11 | 2025-06-12 | 2026-09-01 |
| Trichomylin® Safety, Tolerability & Pharmacokinetics in Healthy Adults and First in Human Osteoarthritis Pain Evaluation Trichomylin for SAD, Placebo for SAD, Trichomylin for MAD - Healthy, Osteoarthritis | Phase 1 | Completed | ZYUS Life Sciences Inc. | 41 | 2021-04-19 | 2024-06-27 |
Cancer Pain (1) · Chronic Pain (1) · Osteoarthritis (1)
Cannabidiol (1) · Dronabinol (1) · Sagittal Abdominal Diameter (1) · cannabichromene (1) · mycophenolic adenine dinucleotide (1)
Australia (1) · Canada (1)
Julie Stakiw, MD (1) · Paul Wabnitz, Dr (1)